The Challenges of Colorectal Cancer Survivorship

Editor:
Kerrin G. Robinson Journal of the National Comprehensive Cancer Network

Search for other papers by Kerrin G. Robinson in
Current site
Google Scholar
PubMed Close
 MA
Authors:
Crystal S. Denlinger From the Departments of Medical Oncology and Nursing, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Search for other papers by Crystal S. Denlinger in
Current site
Google Scholar
PubMed Close
 MD
and
Andrea M. Barsevick From the Departments of Medical Oncology and Nursing, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Search for other papers by Andrea M. Barsevick in
Current site
Google Scholar
PubMed Close
 RN, PhD
Volume/Issue:
Volume 7: Issue 8
Online Publication Date:
Sep 2009
DOI:
https://doi.org/10.6004/jnccn.2009.0058
Full access

With advances in treatment, colorectal cancer (CRC) is being transformed from a deadly disease into an illness that is increasingly curable. With this transformation has come increased interest in the unique problems, risks, needs, and concerns of survivors who have completed treatment and are cancer-free. Research has shown that physical and mental quality of life for CRC survivors was inferior compared with age-matched individuals without cancer. Although issues and symptoms were most prominent during the first 3 years, long-term effects of treatment can persist and include fatigue, sleep difficulty, fear of recurrence, anxiety, depression, negative body image, sensory neuropathy, gastrointestinal problems, urinary incontinence, and sexual dysfunction. The unique challenges and issues of CRC survivors can and should be addressed by health care providers and the research community to ensure effective interventions and models of care to manage these problems. This article discusses what is known about the long-term effects of CRC treatment on quality of life, the care of survivors, and existing models of survivorship care.

Correspondence: Crystal S. Denlinger, MD, Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111. E-mail: crystal.denlinger@fccc.edu

Disclosure: Crystal S. Denlinger, MD, has disclosed that she has received research funding from Merrimack Pharmaceuticals for phase I clinical trials and from Genentech, Inc. for unrelated clinical trials.

Disclosure: Andrea M. Barsevick, RN, PhD, has disclosed no relevant financial relationships.

Disclosure: Kerrin G. Robinson, MA, has disclosed no relevant financial relationships.

  • Collapse
  • Expand
Print ISSN:
1540-1405
Online ISSN:
1540-1413
Publisher:
National Comprehensive Cancer Network
Cover Journal of the National Comprehensive Cancer Network
  • 1

    Rowland JH. What are cancer survivors telling us? Cancer J 2008;14:361–368.

  • 2

    Jemal A, Siegel R, Ward E et al.. Cancer Statistics, 2008. CA Cancer J Clin 2008;58:71–96.

  • 3

    Rim SR, Seeff L, Ahmed F et al.. Colorectal cancer incidence in the United States, 1999–2004. Cancer 2009;115:1967–1976.

  • 4

    Edwards BK, Howe HL, Ries LAG et al.. Annual Report to the Nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden. Cancer 2002;94:2766–2792.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5

    Jemal A, Clegg LX, Ward E et al.. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 2004;101:3–27.

  • 6

    Moertel C, Fleming T, Macdonald J et al.. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322:352–358.

  • 7

    de Gramont A, Boni C, Navarro M et al.. Oxaliplatin/5FU/LV in adjuvant colon cancer: updated efficacy results of the MOSAIC trial, including survival, with a median follow-up of six years [abstract]. J Clin Oncol 2007;25(Suppl 18S):Abstract 4007.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8

    Krook J, Moertel C, Gunderson L et al.. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709–715.

  • 9

    Sauer R, Becker H, Hohenberger W et al.. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731–1740.

  • 10

    Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Washington, D.C.: The National Academies Press; 2006.

  • 11

    Wilson IB, Cleary PD. Linking clinical variable with health-related quality of life. A conceptual model of patients outcomes. JAMA 1995;273:59–65.

  • 12

    Baker F, Haffer SC, Denniston M et al.. Health-related quality of life of cancer and noncancer patients in Medicare managed care. Cancer 2003;97:674–681.

  • 13

    Baker F, Denniston M, Smith T, West MM. Adult cancer survivors: how are they faring? Cancer 2005;104(Suppl 11):2565–2576.

  • 14

    Lynch BM, Steginga SK, Hawkes AL et al.. Describing and predicting psychological distress after colorectal cancer. Cancer 2008;112:1363–1370.

  • 15

    Stein KD, Syrjala KL, Andrykowski MA et al.. Physical and psychological long-term and late effects of cancer. Cancer 2008;112(Suppl 11):2577–2592.

  • 16

    de Boer AG, Taskila T, Ojajarvi A et al.. Cancer survivors and unemployment: a meta-analysis and meta-regression. JAMA 2009;301:753–762.

  • 17

    Hewitt M, Rowland JH, Yancik R et al.. Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci 2003;58:82–91.

  • 18

    Ramsey SD, Berry K, Moinpour C et al.. Quality of life in long term survivors of colorectal cancer. Am J Gastroenterol 2002;97:1228–1234.

  • 19

    Sweeney C, Schmitz KH, Lazovich D et al.. Functional limitations in elderly female cancer survivors. J Natl Cancer Inst 2006;98:521–529.

  • 20

    Deimling GT, Sterns S, Bowman KF, Kahana B. Functioning and activity participation restrictions among older adult, long-term cancer survivors. Cancer Invest 2007;25:106–116.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 21

    Given CW, Given B, Azzouz F et al.. Comparison of changes in physical functioning of elderly patients with new diagnoses of cancer. Med Care 2000;38:482–493.

  • 22

    Given BA, Given C, Azzouz F, Stommel M. Physical functioning of elderly cancer patients prior to diagnosis and following initial treatment. Nurs Res 2001;50:222–232.

  • 23

    Deimling GT, Bowman KF, Wagner LJ et al.. The effects of cancer-related pain and fatigue on functioning of older adult, long-term cancer survivors. Cancer Nurs 2007;30:421–433.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24

    Kurtz ME, Kurtz JC, Stommel M et al.. Predictors of depressive symptomatology of geriatric patients with colorectal cancer: a longitudinal view. Support Care Cancer 2002;10:494–501.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25

    Robb C, Haley WE, Balducci L et al.. Impact of breast cancer survivorship on quality of life in older women. Crit Rev Oncol Hematol 2007;62:84–91.

  • 26

    Hewitt M, Rowland JH, Hewitt M, Rowland JH. Mental health service use among adult cancer survivors: analyses of the National Health Interview Survey. J Clin Oncol 2002;20:4581–4590.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 27

    Mullens AB, McCaul KD, Erickson SC et al.. Coping after cancer: risk perceptions, worry, and health behaviors among colorectal cancer survivors. Psychooncology 2004;13:367–376.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28

    Deimling GT, Sterns S, Bowman KF, Kahana B. The health of older-adult, long-term cancer survivors. Cancer Nurs 2005;28:415–424.

  • 29

    Deimling GT, Wagner LJ, Bowman KF et al.. Coping among older-adult, long-term cancer survivors. Psychooncology 2006;15:143–159.

  • 30

    Stommel M, Kurtz ME, Kurtz JC et al.. A longitudinal analysis of the course of depressive symptomatology in geriatric patients with cancer of the breast, colon, lung, or prostate. Health Psychol 2004;23:564–573.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 31

    Ramsey SD, Andersen MR, Etzioni R et al.. Quality of life in survivors of colorectal carcinoma. Cancer 2000;88:1294–1303.

  • 32

    Schneider EC, Malin JL, Kahn KL et al.. Surviving colorectal cancer: patient-reported symptoms 4 years after diagnosis. Cancer 2007;110:2075–2082.

  • 33

    Trentham-Dietz A, Remington PL, Moinpour CM et al.. Health-related quality of life in female long-term colorectal cancer survivors. Oncologist 2003;8:342–349.

  • 34

    Sapp AL, Trentham-Dietz A, Newcomb PA et al.. Social networks and quality of life among female long-term colorectal cancer survivors. Cancer 2003;98:1749–1758.

  • 35

    Holland JC, Andersen B, Breitbart WS et al.. NCCN Clinical Practice Guidelines in Oncology: Distress Management. Version 2, 2009. Available at: http://www.nccn.org/professionals/physician_gls/PDF/distress.pdf. Accessed July 16, 2009.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 36

    Allal AS, Gervaz P, Gertsch P et al.. Assessment of quality of life in patients with rectal cancer treated by preoperative radiotherapy: a longitudinal prospective study. Int J Radiat Oncol Biol Phys 2005;61:1129–1135.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 37

    Sideris L, Zenasni F, Vernerey D et al.. Quality of life of patients operated on for low rectal cancer: impact of the type of surgery and patients’ characteristics. Dis Colon Rectum 2005;48:2180–2191.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 38

    Guren MG, Eriksen MT, Wiig JN et al.. Quality of life and functional outcome following anterior or abdominoperineal resection for rectal cancer. Eur J Surg Oncol 2005;31:735–742.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 39

    Arndt V, Merx H, Stegmaier C et al.. Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: a population-based study. J Clin Oncol 2004;22:4829–4836.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 40

    Rauch P, Miny J, Conroy T et al.. Quality of life among disease-free survivors of rectal cancer. J Clin Oncol 2004;22:354–360.

  • 41

    Peeters KC, van de Velde CJ, Leer JW et al.. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients—a Dutch Colorectal Cancer Group Study. J Clin Oncol 2005;23:6199–6206.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 42

    Cersosimo RJ. Oxaliplatin-associated neuropathy: a review. Ann Pharmacother 2005;39:128–135.

  • 43

    Grothey A. Oxaliplatin-safety profile: neurotoxicity. Semin Oncol 2003;30:5–13.

  • 44

    Kaley TJ, DeAngelis LM. Therapy of chemotherapy-induced peripheral neuropathy. Br J Haematol 2009;145:3–14.

  • 45

    Cavaletti G, Petruccioli MG, Marmiroli P et al.. Circulating nerve growth factor levels changes during oxaliplatin treatment-induced neurotoxicity in the rat. Anticancer Res 2002;22:4199–4204.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 46

    Gamelin L, Capitain O, Morel A et al.. Predictive factors of oxaliplatin neurotoxicity: the involvement of the oxalate outcome pathway. Clin Cancer Res 2007;13:6359–6368.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 47

    Grolleau F, Gamelin L, Boisdron-Celle M et al.. A Possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels. J Neurophysiol 2001;85:2293–2297.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 48

    Park SB, Goldstein D, Lin CS et al.. Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity. J Clin Oncol 2009;27:1243–1249.

  • 49

    Andre T, Boni C, Mounedji-Boudiaf L et al.. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343–2351.

  • 50

    Kuebler JP, Wieand S, O’Connell MJ et al.. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol 2007;25:2198–2204.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 51

    Land SR, Kopec JA, Cecchini RS et al.. Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07. J Clin Oncol 2007;25:2205–2211.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 52

    Yothers G, Land SR, Ganz PA et al.. Neurotoxicity (NT) in colon cancer (CC) survivors from NSABP protocol C-07 comparing 5-FU + leucovorin (FULV) with the same regimen + oxaliplatin (FLOX): preliminary results from NSABP protocol LTS-01 [abstract]. J Clin Oncol 2008;26(Suppl 1):Abstract 9575.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 53

    Wang WS, Lin JK, Lin TC et al.. Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients. Oncologist 2007;12:312–319.

  • 54

    Cascinu S, Catalano V, Cordella L et al.. Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial. J Clin Oncol 2002;20:3478–3483.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 55

    Gedlicka C, Scheithauer W, Schull B, Kornek GV. Effective treatment of oxaliplatin-induced cumulative polyneuropathy with alpha-lipoic acid. J Clin Oncol 2002;20:3359–3361.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 56

    Argyriou AA, Chroni E, Polychronopoulos P et al.. Efficacy of oxcarbazepine for porphylaxis against cumulative oxaliplatin-induced neuropathy. Neurology 2006;67:2253–2255.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 57

    Mitchell P, Goldstein D, Michael M et al.. Addition of gabapentin to a modified folfox regimen does not reduce oxaliplatin-induced neurotoxicity. Clin Colorectal Cancer 2006;6:146–151.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 58

    von Delius S, Eckel F, Wagenpfeil S et al.. Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: final results of a randomised, controlled, multicenter phase II study. Invest New Drugs 2007;25:173–180.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 59

    Gamelin L, Boisdron-Celle M, Delva R et al.. Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-fluorouracil and leucovorin for advanced colorectal cancer. Clin Cancer Res 2004;10:4055–4061.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 60

    Hochster HS, Grothey A, Shpilsky A, Childs BH. Effect of intravenous (IV) calcium and magnesium (Ca/Mg) versus placebo on response to FOLFOX+bevacizumab (BEV) in the CONcePT trial. Presented at the ASCO 2008 Gastrointestinal Cancers Symposium; Orlando, Florida; January 25–27, 2008.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 61

    Nikcevich DA, Grothey A, Sloan JA et al.. Effect of intravenous calcium and magnesium (IV CaMg) on oxaliplatin-induced sensory neurotoxicity (sNT) in adjuvant colon cancer: results of the phase III placebo-controlled, double-blind NCCTG trial N04C7 [abstract]. J Clin Oncol 2008;26(Suppl 1):Abstract 4009.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 62

    Hochster HS, Grothey A, Childs BH. Use of calcium and magnesium salts to reduce oxaliplatin-related neurotoxicity. J Clin Oncol 2007;25:4028–4029.

  • 63

    Gami B, Harrington K, Blake P et al.. How patients manage gastrointestinal symptoms after pelvic radiotherapy. Aliment Pharmacol Ther 2003;18:987–994.

  • 64

    DeSnoo L, Faithfull S. A qualitative study of anterior resection syndrome: the experiences of cancer survivors who have undergone resection surgery. Eur J Cancer Care (Engl) 2006;15:244–251.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 65

    Birgisson H, Påhlman L, Gunnarsson U, Glimelius B. Late gastrointestinal disorders after rectal cancer surgery with and without preoperative radiation therapy. Br J Surg 2008;95:206–213.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 66

    Dahlberg M, Glimelius B, Graf W, Påhlman L. Preoperative irradiation affects functional results after surgery for rectal cancer. Dis Colon Rectum 1998;41:543–549.

  • 67

    Hassan I, Larson D, Cima R et al.. Long-term functional and quality of life outcomes after coloanal anastomosis for distal rectal cancer. Dis Colon Rectum 2006;49:1266–1274.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 68

    Kollmorgen CF, Meagher AP, Wolff BG et al.. The long-term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function. Ann Surg 1994;220:676–682.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 69

    Lundby L, Krogh K, Jensen VJ et al.. Long-term anorectal dysfunction after postoperative radiotherapy for rectal cancer. Dis Colon Rectum 2005;48:1343–1352.

  • 70

    McGough C, Baldwin C, Frost G, Andreyev HJ. Role of nutritional intervention in patients treated with radiotherapy for pelvic malignancy. Br J Cancer 2004;90:2278–2287.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 71

    Andreyev J. Gastrointestinal complications of pelvic radiotherapy: are they of any importance? Gut 2005;54:1051–1054.

  • 72

    Baxter NN, Habermann EB, Tepper JE et al.. Risk of pelvic fractures in older women following pelvic irradiation. JAMA 2005;294:2587–2593.

  • 73

    Small W Jr, Kachnic L. Postradiotherapy pelvic fractures: cause for concern or opportunity for future research? JAMA 2005;294:2635–2637.

  • 74

    Lange MM, Maas CP, Marijnen CA et al.. Urinary dysfunction after rectal cancer treatment is mainly caused by surgery. Br J Surg 2008;95:1020–1028.

  • 75

    Lange MM, Marijnen CA, Maas CP et al.. Risk factors for sexual dysfunction after rectal cancer treatment. Eur J Cancer 2009;45:1578–1588.

  • 76

    Pollack J, Holm T, Cedermark B et al.. Late adverse effects of short-course preoperative radiotherapy in rectal cancer. Br J Surg 2006;93:1519–1525.

  • 77

    Mannaerts GH, Schijven MP, Hendrikx A et al.. Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer. Eur J Surg Oncol 2001;27:265–272.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 78

    Havenga K, Enker WE, McDermott K et al.. Male and female sexual and urinary function after total mesorectal excision with autonomic nerve preservation for carcinoma of the rectum. J Am Coll Surg 1996;182:495–502.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 79

    Wolf JK. Prevention and treatment of vaginal stenosis resulting from pelvic radiation therapy. Community Oncology 2006;3:665–671.

  • 80

    Lindsey I, George B, Kettlewell M, Mortensen N. Randomized, double-blind, placebo-controlled trial of sildenafil (Viagra) for erectile dysfunction after rectal excision for cancer and inflammatory bowel disease. Dis Colon Rectum 2002;45:727–732.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 81

    Decruze SB, Guthrie D, Magnani R. Prevention of vaginal stenosis in patients following vaginal brachytherapy. Clin Oncol 1999;11:46–48.

  • 82

    Brown JK, Byers T, Doyle C et al.. Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin 2003;53:268–291.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 83

    Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol 2005;23:5814–5830.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 84

    Blanchard CM, Courneya KS, Stein K. Cancer survivors’ adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society’s SCS-II. J Clin Oncol 2008;26:2198–2204.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 85

    Jones LW, Courneya KS, Fairey AS. Effects of an oncologist’s recommendation to exercise on self-reported exercise behavior in newly diagnosed breast cancer survivors: a single-blind, randomized controlled trial. Ann Behav Med 2004;28:105–113.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 86

    Meyerhardt JA, Heseltine D, Niedzwiecki D et al.. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol 2006;24:3535–3541.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 87

    Meyerhardt JA, Giovannucci EL, Holmes MD et al.. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol 2006;24:3527–3534.

  • 88

    Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625–1638.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 89

    Meyerhardt JA, Catalano PJ, Haller DG et al.. Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer 2003;98:484–495.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 90

    Dignam JJ, Polite BN, Yothers G et al.. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst 2006;98:1647–1654.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 91

    Meyerhardt JA, Niedzwiecki D, Hollis D et al.. Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803. J Clin Oncol 2008;26:4109–4115.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 92

    Meyerhardt JA, Tepper JE, Niedzwiecki D et al.. Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. J Clin Oncol 2004;22:648–657.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 93

    Moon H, Ju Y, Jeong C et al.. Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann Surg Oncol 2008;15:1918–1922.

  • 94

    Meyerhardt JA, Niedzwiecki D, Hollis D et al.. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA 2007;298:754–764.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 95

    Fuchs C, Meyerhardt JA, Heseltine DL et al.. Influence of regular aspirin use on survival for patients with stage III colon cancer: findings from Intergroup trial CALGB 89803 [abstract]. J Clin Oncol 2005;23(Suppl 1):Abstract 3530.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 96

    Ng K, Meyerhardt JA, Wu K et al.. Circulating 25-hydroxyvitamin D levels and survival in patients with colorectal cancer. J Clin Oncol 2008;26:2984–2991.

  • 97

    Jackson NA, Fuchs CS, Niedzwiecki D et al.. The impact of smoking on cancer recurrence and survival in patients with stage III colon cancer: findings from Intergroup trial CALGB 89803 [abstract]. J Clin Oncol 2008;26(Suppl 1):Abstract 4039.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 98

    Sargent DJ, Patiyil S, Yothers G et al.. End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT group. J Clin Oncol 2007;25:4569–4574.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 99

    Sargent D, Sobrero A, Grothey A et al.. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 2009;27:872–877.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 100

    Earle CC, Neville BA. Under use of necessary care among cancer survivors. Cancer 2004;101:1712–1719.

  • 101

    Snyder CF, Earle CC, Herbert RJ et al.. Preventive care for colorectal cancer survivors: a 5-year longitudinal study. J Clin Oncol 2008;26:1073–1079.

  • 102

    Haggstrom D, Arora N, Oakley-Girvan I. Primary and subspecialty care models of follow-up care delivery among colorectal cancer survivors [abstract]. J Clin Oncol 2008;26(Suppl 1):Abstract 6540.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 103

    Snyder C, Earle C, Herbert R et al.. Trends in follow-up and preventive care for colorectal cancer survivors. J Gen Intern Med 2008;23:254–259.

  • 104

    Nissen MJ, Beran MS, Lee MW et al.. Views of primary care physicians on follow-up care of cancer patients. Fam Med 2007;39:477–482.

  • 105

    Sabatino SA, Coates RJ, Uhler RJ et al.. Provider counseling about health behaviors among cancer survivors in the United States. J Clin Oncol 2007;25:2100–2106.

  • 106

    Oeffinger KC, McCabe MS. Models for delivering survivorship care. J Clin Oncol 2006;24:5117–5124.

  • 107

    Earle CC. Failing to plan is planning to fail: improving the quality of care with survivorship care plans. J Clin Oncol 2006;24:5112–5116.

  • 108

    Berger AM, Abernethy AP, Atkinson A et al.. NCCN Clinical Practice Guidelines in Oncology: Cancer-Related Fatigue. Version 1, 2009. Available at: http://www.nccn.org/professionals/physician_gls/PDF/fatigue.pdf. Accessed July 16, 2009.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 109

    Mitchell SA, Beck SL, Hood LE et al.. Putting evidence into practice: evidence-based interventions for fatigue during and following cancer and its treatment. Clin J Oncol Nurs 2007;11:99–113.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 110

    Page MS, Berger AM, Johnson LB. Putting evidence into practice: evidence-based interventions for sleep-wake disturbances. Clin J Oncol Nurs 2006;10:753–767.

Copyright:
Copyright © 2009 by the National Comprehensive Cancer Network 2009
Page Numbers:
12
Article Category:
Research Article
Received:
12 Mar 2009
Accepted:
04 Jun 2009
Print Publication Date:
01 Sep 2009
Online Publication Date:
Sep 2009
Keywords:
Colorectal cancer; survivorship; quality of life; late effects; long-term effects

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 4812 1377 133
PDF Downloads 2040 442 48
EPUB Downloads 0 0 0